openPR Logo
Press release

Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG

08-26-2024 11:12 PM CET | Health & Medicine

Press release from: ABNewswire

Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics,

DelveInsight's, "Influenza Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Influenza pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Influenza Pipeline. Dive into DelveInsight's comprehensive report today! @ Influenza Pipeline Outlook [https://www.delveinsight.com/sample-request/influenza-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Key Takeaways from the Influenza Pipeline Report

* August 2024:- Hoffmann-La Roche- A Phase IIIb Multicenter, Single-Arm, Open-Label Surveillance Study of Susceptibility to Baloxavir Marboxil in Patients With Influenza. The purpose of this study is to evaluate the pre-treatment and single-dose post treatment susceptibility of baloxavir marboxil in participants aged 1 to
* August 2024:- Janssen Vaccines & Prevention B.V.- A Randomized, Double-blind, Placebo-controlled, First-in-human Phase 1/2a Study to Evaluate Safety, Reactogenicity and Immunogenicity of a Universal Influenza (Uniflu) Vaccine With INFLUENZA G1 mHA in Healthy Adults. The primary purpose of this study is to evaluate safety/ reactogenicity of INFLUENZA G1 mini-hemagglutinin stem-derived protein vaccine antigen (mHA), with or without Al(OH)3 adjuvant, in healthy adults greater than or equal to (>=) 18 to less than or equal to (



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG here

News-ID: 3635365 • Views:

More Releases from ABNewswire

Yasam Ayavefe and the Future Direction of Mileo Mykonos in a 2026 Travel Era
Yasam Ayavefe and the Future Direction of Mileo Mykonos in a 2026 Travel Era
Yasam Ayavefe and Mileo Mykonos Future Direction 2026 Yasam Ayavefe is an entrepreneur and philanthropist who looks at hospitality as a long-term journey, not a short-term trend. As travel habits evolve and demand increases, his standpoint helps to clarify the position of Mileo Mykonos [http://www.mileomykonos.com/] in the 2026 travel era. The emphasis is not on luxury but on louder or rapid expansion. The emphasis is on considerate comfort, cultural tolerance, and
New Science Fiction Novel
New Science Fiction Novel "Echoes of Venus" Examines Life After Death on an Alie …
Imagine waking up after your death, not in some far-off, fantastical heaven, but on an alien planet, in a body that's not your own. This is the journey of John Carter in Echoes of Venus, the captivating debut novel by Michael Anthony Cariola. Available now, this thrilling sci-fi adventure is a perfect blend of high-stakes action and deep, philosophical questions about what it means to truly live. John Carter, at 77
Understanding Mental Health Treatment: How Evidence-Based Care Supports Long-Term Recovery
Understanding Mental Health Treatment: How Evidence-Based Care Supports Long-Ter …
Seeking mental health assistance is initially intimidating. You might have a clue that things are not okay, but you might not be in on what kind of support is going to be effective. The actual curing is not a couple of talks or hints. These are aimed at getting you to know what is occurring, learn practical skills, and develop a plan that you can adhere to in the day-to-day
Dymesty Unveils Next-Generation AI Glasses, Bringing Premium Titanium Wearables to Market with Built-In AI Assistant
Dymesty Unveils Next-Generation AI Glasses, Bringing Premium Titanium Wearables …
Image: https://www.abnewswire.com/upload/2026/01/ce4b080ca152df9ad5784609e5dc2abd.jpg Imagine your glasses starting to think. That is what happens with Dymesty AI Glasses [https://dymesty.com/], where regular frames meet quiet intelligence. Not loud, not flashy - just useful. A shift shows up quietly: tools that once lived inside phones now sit on your face. Information flows with upout asking twice. Tasks shrink down into glances. The surroundings talk back in helpful ways. People who work hard find new rhythms.

All 5 Releases


More Releases for Influenza

Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies …
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza …
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780 This latest report researches the industry structure, sales, revenue,
Influenza Medication Market - Fight off the influenza virus with effective and r …
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859 This latest report researches the industry structure, sales, revenue,
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced …
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, which
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating …
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, which
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,